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To the Editor: 
Persistent or fixed airflow obstruction (FAO) is prevalent in up to 60% of patients with severe 
asthma[1] and is associated with older age, more rapid decline in lung function and increased 
symptoms[1-3]. The underlying mechanisms of FAO in asthma are unknown, but growing evidence 
suggest that parenchymal changes resulting in loss of elastic recoil and decreased lung stiffness (i.e. 
increased lung compliance) contribute to FAO[2, 4]. In a recent study of older asthma patients with 
FAO, decreased lung stiffness was the sole predictor of more severe airflow obstruction, as 
measured by reduced FEV1/FVC ratio[2].  
 
Obesity is a common comorbidity of asthma, including those with FAO[3], and is associated with 
increased symptoms and reduced response to standard treatments, but not with more severe 
airflow obstruction[5, 6]. The relationship between obesity and asthma is complex and potentially 
involves an interaction of inflammatory, mechanical and genetic factors. The classic abnormality in 
obesity is reduced operating lung volume, which decreases the lung’s recoil on the airways thus 
reducing airway calibre; this could explain asthma-like symptoms such as dyspnea and wheeze, even 
in patients without asthma and may contribute to airway hyperresponsiveness[7]. In addition, 
obesity changes the mechanics of the lungs such that lungs are stiffer and elastic recoil is increased 
(pressure at any given lung volume)[8]. Thus, changes in the lung’s elastic properties would 
theoretically counteract any effects of low lung volume and asthmatic bronchoconstriction on 
airway narrowing i.e. obesity might counteract airflow obstruction in asthma. This has not been 
tested in asthma with no published data on the relationship between body mass index (BMI) vs lung 
stiffness or elastic recoil in asthmatic participants. Therefore, the aim of this study was to determine 
the relationship between BMI vs lung stiffness and elastic recoil pressures, in asthmatic participants 
with FAO and a range of impairment of FEV1/FVC. We hypothesised that increasing BMI would 
increase lung stiffness and increase elastic recoil pressures. Some data from this cohort has been 
previously published[2], however the relationships with BMI examined in this study are novel.  
 
Individuals with a physician-diagnosis of asthma who were ≥40 years old and were current non-
smokers with a smoking history ≤5 pack-years, were recruited from hospital clinics[2]. All patients 
were treated with high-dose inhaled fluticasone/eformoterol combination treatment of 
1000/40µg/day for 2 months to control any steroid-responsive inflammation. Participants 
performed standard pulmonary function tests according to ATS/ERS standards after 2 months of 
treatment. Post-bronchodilator spirometry was performed to confirm FAO, defined as an 
insignificant bronchodilator (BD) response post inhaled salbutamol 400 mcg with reduced baseline 
FEV1[2]. Lung elastic recoil pressure was measured using an oesophageal balloon as previously 
described[2]. Briefly, the pressure-volume (P-V) curve was constructed from pooled datapoints from 
five interrupted deflation manoeuvres from total lung capacity (TLC) to functional residual capacity 
(FRC). At least 30 acceptable datapoints were plotted and an exponential function, V=A-Be−KP was 
fitted to the P-V curve between 50% and 100% of TLC using a least-squares fit; V is volume, A is the 
horizontal asymptote, and B is the distance between A and the extrapolated y-axis intercept. The 
ratio of B/A, expressed as a percentage, is an index of lung elastic recoil pressure; a high ratio 
indicates increased recoil pressure (rightward shift of the P-V curve). K is an index of the curvature of 
the exponential relationship between P and V as a measure of lung stiffness. Decreased K indicates a 
reduced slope of the P-V curve at lower lung volumes near FRC hence, increased stiffness. Predicted 
values were calculated using published equations[9]. Correlations between BMI and lung function 
measurements were assessed using Spearman’s rank test.  
 
Eighteen asthmatic participants with a mean age±SD of 64.1±8.0 years were enrolled. Median(IQR) 
BMI was 27.8(24.6-31.0)kg/m2; 5/18 of patients were obese (BMI>30kg/m2), 8/18 were overweight 
(BMI:25-30kg/m2), and 5/18 were of normal weight (BMI<18.5-24.9kg/m2). All participants were 
taking ICS with or without a LABA. Mean post-bronchodilator FEV1/FVC ratio was 0.57±0.08 (mean z-
score:-2.6±0.7) and was within normal range in 2 participants despite having reduced FEV1. Both 
participants had a clear history of asthma with a positive methacholine challenge test, history of 
positive bronchodilator response and normal TLC measured by plethysmography. Gas trapping 
defined as RV/TLC z-score >1.64, was present in 6/18(33%) of participants. Median (IQR) lung elastic 
recoil (B/A%) in this cohort was 52 (44-77) and was reduced in 5/18 (28%) of participants and 
median (IQR) lung stiffness (K) was 0.197 (0.131-0.267) cmH2O
-1 and  was reduced in 9/18 (50%) of 
participants. B/A and K were correlated to each other (rs=-0.53, p=0.02) and 4 out of the 5 
participants with low elastic recoil also had reduced lung stiffness. 
 
 
Higher BMI was associated with increased lung stiffness (lower K % predicted) (rs=-0.65, p=0.003) 
and higher FEV1/FVC % predicted (rs=0.74, p=0.0005) (Figures 1A-B). Higher BMI was also related to 
lower FRC (rs=-0.50, p=0.04) (Figure 1C), but not to measurements of lung elastic recoil (B/A%) 
(Figure 1D) (rs=0.28, p=0.26), gas trapping (RV/TLC) (rs=0.10, p=0.7), FVC (rs=-0.30, p=0.23) or TLC 
(rs=-0.4, p=0.1) (all % predicted). 
 
In summary, in this small study of asthma patients over the age of 40 years with FAO and negligible 
smoking history, higher BMI was associated with less airflow obstruction and with stiffer lungs but 
was unrelated to lung elastic recoil pressure, FVC or TLC. These results suggest that higher BMI might 
be protective of airflow obstruction in asthma by opposing the effects of asthma on lung stiffness. 
 
The association between increased lung stiffness (reduced compliance) and increased BMI is 
consistent with previous findings in healthy individuals[10, 11] however, these measurements were 
made in supine position and under general anaesthesia which may have affected results. The novel 
finding in our study is that higher BMI is similarly associated with increased lung stiffness in 
asthmatic participants with FAO. Although the mechanisms by which obesity increases lung stiffness 
in asthma are unknown, several mechanisms may contribute. In obesity, pleural pressure is 
increased (i.e. less negative) and transpulmonary pressure is reduced (i.e. less positive), that is, the 
lung parenchyma experiences less distending pressure[12]. This may promote peripheral airway 
closure and atelectasis in the dependent lung zones, which has been observed to be greater in obese 
participants during bronchoconstriction[13]. Basal airway closure and atelectasis may in turn, 
increase lung stiffness. A recent ventilation imaging study in obese but non-asthmatic participants 
showed increased ventilation to the upper, non-dependent lung regions and altered distributions of 
airway narrowing during bronchoconstriction[14]. The authors argued that increased lung stiffness 
may have contributed to the altered ventilation distribution.  
 
Another possible contributing factor to the reduced lung compliance is surfactant dysfunction 
related to obesity and/or asthma. Pulmonary surfactant reduces the surface tension at the air-liquid 
interface, preventing airway collapse at end-expiration. Adipose tissue releases systemic 
inflammatory adipokines and cytokines that may deactivate surfactant, thus increasing surface 
tension and reducing lung compliance. This is consistent with a previous study that demonstrated an 
association between alterations in surfactant proteins and increased lung stiffness in an animal 
model of obesity[15]. The increase in airway closure during bronchial challenge in non-asthmatic 
obese participants is also in keeping with surfactant dysfunction[13, 16]. 
 
Adipose tissue might also affect lung stiffness by its presence in the airways. Transverse airway 
sections from post-mortem lungs of asthmatic and non-asthmatic individuals demonstrated adipose 
tissue within the airway wall, which was related to BMI[17]. This might result in thickening of the 
airway wall and increased airway wall stiffness. This in turn may contribute to increased overall lung 
stiffness since during lung inflation, airways must also distend because of parenchymal 
tethering[18], thus contributing to the pressure required to inflate the lungs to the same extent. It is, 
however, difficult to disentangle between effects on lung vs airway wall stiffness.  
 
Lungs become less stiff with age in healthy participants. In the present study, BMI was unrelated to 
age and therefore, the relationships we report are not due to younger participants having a higher 
BMI. Although lung stiffness was inversely associated with increasing age (rs=0.5, p=0.035), this 
relationship was marginal and driven by one data point and therefore, is not likely to be 
physiologically important.  
 
In summary, we found that higher BMI was associated with less airflow obstruction, which was 
potentially mediated through BMI-related mechanisms which increase lung stiffness. This study 
confirms that obesity interacts with asthma in a complex manner and affects the lung elastic 
properties. Thus, higher BMI may be protective of airflow obstruction in this asthma phenotype but 
could also alter airway behaviour during airway smooth muscle constriction, thereby modifying the 
clinical manifestations of asthma in obesity.  
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